Two Sigma Securities’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,214
Closed -$53.2K 2170
2025
Q3
$53.2K Buy
+18,214
New +$43.1K 0.01% 978
2024
Q4
Sell
-1,264
Closed -$7.72K 3466
2024
Q3
$7.72K Sell
1,264
-1,218
-49% -$8.48K ﹤0.01% 2640
2024
Q2
$22.7K Buy
2,482
+1,503
+154% +$17.7K ﹤0.01% 2677
2024
Q1
$12.1K Buy
+979
New +$12.2K ﹤0.01% 2741
2019
Q2
Sell
-54
Closed -$13K 2494
2019
Q1
$13K Buy
+54
New +$13.6K ﹤0.01% 1709
2018
Q4
Sell
-76
Closed -$21K 2941
2018
Q3
$21K Buy
76
+11
+17% +$3.31K ﹤0.01% 2437
2018
Q2
$22K Buy
+65
New +$21.4K ﹤0.01% 2559
2017
Q4
Sell
-104
Closed -$55K 2063
2017
Q3
$55K Buy
+104
New +$55.3K 0.01% 734

Other funds holding VIVS

Two Sigma Securities's VIVS Position: Q4 2025 in Review

Two Sigma Securities sold out of VivoSim Labs (VIVS) in Q4 2025, closing a stake of 18,214 shares — an estimated $53.2K sold.

Two Sigma Securities first reported a position in VIVS in Q3 2017 and held it in 8 quarters. The position peaked at $55K in Q3 2017. 27 funds tracked by Wall St. Rank hold VIVS as of Q4 2025.

  • Two Sigma Securities reported no remaining VivoSim Labs position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,214 VivoSim Labs shares in Q4 2025, an estimated $53.2K.
  • Two Sigma Securities first reported a position in VivoSim Labs in Q3 2017 and held it in 8 quarters.
  • Two Sigma Securities's VivoSim Labs position peaked at $55K in Q3 2017.
  • 27 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.